Astellas’ gastric cancer therapy gets the go-ahead from UK regulator
The UK health regulator said it approved Astellas Pharma’s therapy to treat a type of gastric cancer. The monoclonal antibody, which will be marketed under the brand name Vyloy, can recognise certain cancer cells and attach to and destroy them.
ENTRADAS POPULARES
Poland prepares for peaking floods
septiembre 20, 2024
Italy evacuates thousands as Boris hits the north
septiembre 20, 2024
China and the US race to tame nuclear fusion for clean energy
septiembre 20, 2024
TRANSMISIÓN EN VIVO